Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study

NCT: NCT02990247 · COMPLETED

NCT IDNCT02990247
StatusCOMPLETED
Start Date2016-11-14
Completion2018-11-06

Brief Summary

Asthma exacerbations account for a significant morbidity and disproportionate health care costs. However, there is no currently available biomarker or lung function parameter that can accurately predict the risk of future exacerbations. The current work aims at evaluating the resting ventilatory flow by applying a new technique called anharmonic morphological analysis of the respiratory signals (AMARS). We hypothesize that monitoring AMARS is potentially able to detect an increased risk of asthma exacerbations.

Frequently Asked Questions

What is Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study?

Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study is a clinical trial registered under NCT02990247. Current status: COMPLETED.

What is the status of NCT02990247?

The current status of NCT02990247 (Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study) is: COMPLETED.

When did Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study start?

Home Telemonitoring of Resting Spontaneous Breathing in Severe Asthma: a Pilot Study started on 2016-11-14.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.